News & Updates

Bempedoic acid shows long-term efficacy, safety

12 May 2022

In patients with atherosclerotic cardiovascular disease, continued treatment with bempedoic acid for up to 2.5 years effectively keeps levels of low-density lipoprotein cholesterol (LDL-C) low, while also being generally well-tolerated, according to the results of a phase 3, open-label extension (OLE) study.

Bempedoic acid shows long-term efficacy, safety

12 May 2022

Infertility liked to higher risk of atherosclerotic cardiovascular disease

11 May 2022

Women with a history of infertility have a moderately higher risk of atherosclerotic cardiovascular disease (ASCVD) compared with those who have no such history, with the risk more pronounced among nulliparous infertile women who have or have not experienced a pregnancy loss, according to a study.

Infertility liked to higher risk of atherosclerotic cardiovascular disease

11 May 2022

Supplemental calcium may do more harm than good in older patients with aortic stenosis

10 May 2022

For elderly patients with mild-moderate aortic stenosis, calcium supplementation with or without vitamin D may lead to unfavourable outcomes, such as lower survival and increased risk of aortic valve replacement, according to a study.

Supplemental calcium may do more harm than good in older patients with aortic stenosis

10 May 2022

Early neurosurgery tied to better survival in spontaneous haemorrhagic stroke

09 May 2022

Neurosurgery performed 2–4 hours after presenting to the emergency department (ED) seems to result in better survival outcomes in patients with spontaneous haemorrhagic stroke, reports a recent study.

Early neurosurgery tied to better survival in spontaneous haemorrhagic stroke

09 May 2022

Breast arterial calcification may indicate CVD risk in postmenopausal women

09 May 2022 by

Breast arterial calcification (BAC), as viewed on screening mammograms, may suggest a risk of cardiovascular disease (CVD) in postmenopausal women, a recent US-based study showed.

Breast arterial calcification may indicate CVD risk in postmenopausal women

09 May 2022

$Sacubitril/valsartan useful in heart failure with reduced ejection fraction$

Sacubitril/valsartan useful in heart failure with reduced ejection fraction

09 May 2022

Treatment with sacubitril/valsartan appears to improve right ventricular performance and pulmonary hypertension among patients with heart failure with reduced ejection fraction (HFrEF), independent of the reverse remodelling of the left ventricle, as reported in a study.

Sacubitril/valsartan useful in heart failure with reduced ejection fraction

09 May 2022

11 causal risk factors for CVD that can be modified

08 May 2022

A systematic Mendelian randomization study has identified several modifiable cardiovascular disease (CVD) causal risk factors, including hypertension, smoking, and high body mass index.

11 causal risk factors for CVD that can be modified

08 May 2022

Platelet function a potential biomarker of Alzheimer’s disease

07 May 2022

A higher platelet response in middle-aged individuals who are free of antiplatelet therapy carries an increased risk of dementia in late life, according to a cohort study with 20 years of follow up.

Platelet function a potential biomarker of Alzheimer’s disease

07 May 2022

Cardiorespiratory fitness offsets aggravating effect of inflammation on sudden cardiac death

06 May 2022

Cardiorespiratory fitness (CRF) and inflammation are both independently linked to sudden cardiac death (SCD) in middle-aged men, reports a recent study. However, better CRF seems to offset the impact of inflammation on SCD risk.

Cardiorespiratory fitness offsets aggravating effect of inflammation on sudden cardiac death

06 May 2022

Original New Drug Application Approvals by US FDA (16 - 30 April 2022)

05 May 2022

New drug applications approved by US FDA as of 16-30 April 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 30 April 2022)

05 May 2022

News & Updates

Filter by Specialty:

Specialty:

Bempedoic acid shows long-term efficacy, safety

Bempedoic acid shows long-term efficacy, safety

Infertility liked to higher risk of atherosclerotic cardiovascular disease

Infertility liked to higher risk of atherosclerotic cardiovascular disease

Supplemental calcium may do more harm than good in older patients with aortic stenosis

Supplemental calcium may do more harm than good in older patients with aortic stenosis

Early neurosurgery tied to better survival in spontaneous haemorrhagic stroke

Early neurosurgery tied to better survival in spontaneous haemorrhagic stroke

Breast arterial calcification may indicate CVD risk in postmenopausal women

Breast arterial calcification may indicate CVD risk in postmenopausal women

Sacubitril/valsartan useful in heart failure with reduced ejection fraction

Sacubitril/valsartan useful in heart failure with reduced ejection fraction

11 causal risk factors for CVD that can be modified

11 causal risk factors for CVD that can be modified

Platelet function a potential biomarker of Alzheimer’s disease

Platelet function a potential biomarker of Alzheimer’s disease

Cardiorespiratory fitness offsets aggravating effect of inflammation on sudden cardiac death

Cardiorespiratory fitness offsets aggravating effect of inflammation on sudden cardiac death

Original New Drug Application Approvals by US FDA (16 - 30 April 2022)

Original New Drug Application Approvals by US FDA (16 - 30 April 2022)